We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioNano Genomics Appoints Mike Ward to the Senior Executive Management Team
News

BioNano Genomics Appoints Mike Ward to the Senior Executive Management Team

BioNano Genomics Appoints Mike Ward to the Senior Executive Management Team
News

BioNano Genomics Appoints Mike Ward to the Senior Executive Management Team

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BioNano Genomics Appoints Mike Ward to the Senior Executive Management Team"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioNano Genomics has announced the appointment of Mr. Mike Ward as a member of the senior executive management team and vice president, corporate development. Mr. Ward has more than 20 years of life sciences-dedicated investment banking, venture capital and private equity experience.

"With his impressive track record in mergers and acquisitions as a life sciences-dedicated investment banker and in corporate development for healthcare portfolio companies as a private equity investor, we are confident that Mike will help to further expand the reach of BioNano’s technology and commercialization. Mike has dedicated his career over the past two decades to creating value-added strategic transaction opportunities for life sciences companies," said Erik Holmlin, president and CEO of BioNano Genomics.

Holmlin continued, "Mike will be a great addition to the senior management team as we further advance BioNano Genomics as the leading provider of genome mapping technology and continue to accelerate placement of Irys instruments globally."

Before joining BioNano Genomics, Mr. Ward was at Lurie Investment Fund where he was responsible for managing the life sciences venture capital and private equity investments of the Lurie family.

Mr. Ward guided senior executive management teams of Lurie’s life sciences portfolio companies in conducting business and corporate development, clinical and regulatory strategy, commercialization planning, intellectual property management, M&A and financings. During his tenure, he also served on the boards of a number of life sciences portfolio companies on behalf of Lurie.

Prior to joining Lurie Investment Fund in 2009, Mr. Ward gained more than 15 years of investment banking experience at Leerink Partners, Credit Suisse, Dresdner Kleinwort Wasserstein, BMO and Vector Securities.

During his career in investment banking, Mr. Ward executed more than 80 life sciences mergers, acquisitions, divestitures, strategic alliances, private placements, IPOs and follow-on public offerings.

In his more than two decades of experience fostering the development of life sciences companies, he focused predominantly on medical technology, tools, diagnostics and biopharmaceutical markets.

Advertisement